Open Accessibility Menu

Earl Gross, MD

Insurances Accepted: Aetna, BCBS, Medicare and Medicaid, Tricare
Affiliations Clinical Asst. Professor ECU School of Medicine, Fellow, American Academy of Dermatology, Member American Academy of Dermatopathology, NC Dermatology Association, NC Medical Association, Carteret Medical Society
  • Board Certification
  • American Board of Pathology, Dermatopathology
  • American Board of Dermatology, Dermatology
  • Fellowship
  • Cleveland Metro Health Medical Center
  • Medical School
  • Temple University School of Medicine
  • Residency
  • The Mayo Clinic, Cleveland Metro General Hospital
  • Training
  • Diseases of the Skin, Skin Cancer
Medical Interests Research Interests:

  • Extensive research experience includes evaluations of topical non-steroidal anti-inflammatory agent in plaque type psoriasis, nutrient solution for Decubitus Ulcers, topical, retinoid AGN 168190 for plaque type psoriasis, Itraconazole for Onychomycosis in Diabetics. Participation in a multicenter clinical trial “The Nutritional Prevention of Skin Cancer with Oral Selenium”. Medical Expert for Dermatologic therapy with systemic retinoids. Medical Expert for Clinical Intervention Trials for Cancer Prevention.
  • Teaching Experience includes:
  • Assistant Professor, Pathology Department, University of Connecticut Health Center
  • Associate Professor, Division of Dermatology, Department of Medicine John Dempsey Hospital and Newington VAMC, University of Connecticut Health Center, Farmington and Newington, Connecticut
  • Assistant Clinical Professor, George Washington University School of Medicine
  • Publications:
  • Onychomycosis: Management considerations in diabetes. 1998
  • Randomized open-label study of itraconazole capsules versus palliative care for onychomycosis of the toenail in diabetic patients: The safety experience of itraconazole in the diabetic population. JAPMA. 1998
  • Cancer screening in primary care: Strategies for your office. Connecticut Medicine. 1997
  • Relationship between sunlight exposure and a key genetic alteration in basil cell carcinoma. JNCI. 1996.